Accuracy-based proficiency testing for testosterone measurements with immunoassays and liquid chromatography-mass spectrometry☆
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Accuracy-based proficiency testing for testosterone measurements with immunoassays and liquid chromatography-mass spectrometry☆

Filetype[PDF-535.43 KB]


Details Supporting Files You May Also Like

Details:

  • Alternative Title:
    Clin Chim Acta
  • Publisher's site:
    http://dx.doi.org/10.1016/j.cca.2017.03.010
  • Personal Author:
  • Description:
    Background

    Accurate testosterone measurements are needed to correctly diagnose and treat patients. Proficiency Testing (PT) programs using modified specimens for testing can be limited because of matrix effects and usage of non-reference measurement procedure (RMP)-defined targets for evaluation. Accuracy-based PT can overcome such limitations; however, there is a lack of information on accuracy-based PT and feasibility of its implementation in evaluation for testosterone measurements.

    Methods

    Unaltered, single-donor human serum from 2 male and 2 female adult donors were analyzed for testosterone by 142 NYSDH-certified clinical laboratories using 16 immunoassays and LC-MS/MS methods. Testosterone target values were determined using an RMP.

    Results

    The testosterone target concentrations for the 4 specimens were 15.5, 30.0, 402 and 498 ng/dl. The biases ranged from −17.8% to 73.1%, 3.1% to 21.3%, −24.8% to 8.6%, and −22.1% to 6.8% for the 4 specimens, respectively. Using a total error target of ±25.1%, which was calculated using the minimum allowable bias and imprecision, 73% of participating laboratories had ≥3 of the 4 results within these limits.

    Conclusions

    The variability in total testosterone measurements can affect clinical decisions. Accuracy-based PT can significantly contribute to improving testosterone testing by providing reliable data on accuracy in patient care to laboratories, assay manufacturers, and standardization programs.

  • Subject:
  • Source:
    Clin Chim Acta. 469:31-36.
  • Pubmed ID:
    28288785
  • Pubmed Central ID:
    PMC5695555
  • Document Type:
    Journal Article
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
  • File Type:

You May Also Like

Checkout today's featured content at stacks.cdc.gov